Cargando…
Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
Autores principales: | Sahebkar, Amirhossein, Banach, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476870/ https://www.ncbi.nlm.nih.gov/pubmed/28631417 http://dx.doi.org/10.1002/jcsm.12215 |
Ejemplares similares
-
Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021) -
Management of statin myopathy
por: Finsterer, Josef, et al.
Publicado: (2017) -
Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020) -
CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020) -
Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)